Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELETRIPTAN HYDROBROMIDE Cause Drug ineffective? 502 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 502 reports of Drug ineffective have been filed in association with ELETRIPTAN HYDROBROMIDE (Eletriptan hydrobromide). This represents 23.3% of all adverse event reports for ELETRIPTAN HYDROBROMIDE.

502
Reports of Drug ineffective with ELETRIPTAN HYDROBROMIDE
23.3%
of all ELETRIPTAN HYDROBROMIDE reports
0
Deaths
33
Hospitalizations

How Dangerous Is Drug ineffective From ELETRIPTAN HYDROBROMIDE?

Of the 502 reports, 33 (6.6%) required hospitalization.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELETRIPTAN HYDROBROMIDE. However, 502 reports have been filed with the FAERS database.

What Other Side Effects Does ELETRIPTAN HYDROBROMIDE Cause?

Migraine (310) Headache (246) Malaise (143) Nausea (127) Pain (116) Recalled product administered (115) Vomiting (110) Off label use (106) Condition aggravated (91) Drug hypersensitivity (84)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which ELETRIPTAN HYDROBROMIDE Alternatives Have Lower Drug ineffective Risk?

ELETRIPTAN HYDROBROMIDE vs ELEXACAFTOR\IVACAFTOR\TEZACAFTOR ELETRIPTAN HYDROBROMIDE vs ELIGLUSTAT ELETRIPTAN HYDROBROMIDE vs ELIQUIS ELETRIPTAN HYDROBROMIDE vs ELOSULFASE ALFA ELETRIPTAN HYDROBROMIDE vs ELOTUZUMAB

Related Pages

ELETRIPTAN HYDROBROMIDE Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective ELETRIPTAN HYDROBROMIDE Demographics